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ABSTRACT 
Glomerular damage accounts for the majority of chronic kidney disease 
cases, the prevalence of which is dramatically escalating worldwide, mainly due to 
increase in diabetes and associated nephropathy. The costs for treatment of CKD 
represent an enormous burden to the health care system. Chronic kidney disease 
frequently progresses to end-stage renal disease with the only curative treatment 
options today are lifelong dialysis or kidney transplantation. In order to better 
understand and treat glomerular disease before it has reached this irreversible 
stage, it is imperative to understand the cell biology and physiology of the 
glomerulus including delineation of the molecular make-up of glomerular filtration 
barrier. This barrier constitutes the endothelial cells of the glomerular capillaries 
with its bound surface layer of a carbohydrate-rich meshwork (glycocalyx), the 
glomerular basement membrane, and the podocytes with the sub podocytes space 
and the attached slit diaphragm spanning between neighboring and interdigitating 
foot processes. Even though the concerted interplay of all layers of the glomerular 
filtration barrier is important for the ultra-filtration of the plasma, the podocytes and 
their injuries have recently been acknowledged as the major culprit of glomerular 
disease. 
 
In this thesis work, I describe two novel podocyte specific proteins, TDRD5 
and RHPN1, which we show in vivo to be important for the integrity of the 
glomerular filtration barrier.  
TDRD5 has previously been considered a male germ cell line specific protein 
important for retro transposon silencing and spermiogenesis in mice. Here I show 
that it is expressed in mouse and human podocytes and is enriched in the 
zebrafish glomerulus. By using the in vivo morpholino knock down technique in 
zebrafish larvae it was demonstrated that TDRD5 expression is required for the 
proper formation of the zebrafish pronephros 
RHPN1 is a RHOA binding protein which functions as an attenuator of the 
polymerization of actin stress fibers by regulating the phosphorylation of nonmuscle 
myosin II regulatory light chain through RHOA downstream effectors. Deletion of 
the Rhpn1 gene leads to neonatal albuminuria and glomerular basement 
membrane abnormality. The phenotype was characterized.  
As a part of efforts to elucidate expression signatures of glomerular diseases, the 
global glomeruli expression pattern of Adriamycin treated nephrotic mice was 
analyzed by RNA sequencing. The Adriamycin induced nephropathy mouse model 
mimics the human disease focal segmental glomerular sclerosis which constitutes 
one of the main causes of chronic kidney disease.  
The diabetic nephropathy associated single nucleotide polymorphism 3q locus was 
shown in our work to be a remote cis-acting variant differentially regulating 
glomerular NCK1 expression, implicating an important role for glomerular NCK1 in 
diabetic nephropathy pathogenesis. 
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1 INTRODUCTION: REVIEW OF LITERATURE  
1.1 KIDNEY GENERAL ANATOMY AND FUNCTION 
The kidneys are two bean shaped organs located at the rear of the abdominal 
cavity. They receive about 20 % of the cardiac output and drain blood from the 
paired renal arteries and veins, respectively. The kidneys filter small molecules and 
waste products from the blood and excrete a part of them into the urine, while the 
rest is reabsorbed from the ultra-filtrate (primary urine) and re-entered into the 
blood circulation. In this way, the kidneys produce daily about 180 liters of primary 
filtrate most of which is reabsorbed in the tubules, generating approximately one 
liter of excreted urine a day. Proper secretion and reabsorption of electrolytes and 
other compounds ensures that the body’s homeostasis is maintained regulating 
both pH and blood pressure. Plasma proteins of the size of albumin or larger do 
not pass the kidney filter, which allows important macromolecules such as 
immunoglobulins and transport proteins to be retained in the blood and also 
albumin which maintains the osmolality of the plasma. The kidneys are also part of 
the endocrine system both producing and acting upon hormonal signals (1-3).  
1.1.1 Nephron 
 
The nephron (Figure 1b, c), the main functional unit of the kidney, is composed of 
the renal corpuscle, which is situated at the distal end in the kidney cortex, and 
tubule, which reaches far into the medulla prior to its connection with the collecting 
duct system and ureter before spilling out into the urinary bladder. The renal 
corpuscle constitutes the Bowman’s capsule and the glomerular tuft made of 
capillaries that have branched out of small arterioles (Figure 4).  Oxygenated blood 
enters the kidney trough the renal artery, which is stepwise arborized into smaller 
arterioles which finally reach the afferent arterioles that enter the Bowman’s 
capsule of the ~1 million nephrons of the human kidney. Small water-soluble waste 
products and other solutes that are filtered from the blood form the primary urine of 
the Bowman’s space. The large volume of primary urine is then progressively 
diminished as it is led into the proximal tubule and further through the tubular 
system while continuously being absorbed by the tubular epithelial cells and 
transported to the underlying associated capillaries and interstitium. Via the 
collecting duct and ureter approximately one liter per day enters the bladder that is 
finally excreted through the urethra. 
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Figure1. The urinary system of the kidney. a) A cross section of the kidney b) Different parts of the 
nephron. c) The nephron here with the peritubular capillaries which allows for the reabsorption and 
secretion between blood and the filtrate of the nephron (Reprint cae1.com). 
1.1.1.1. Renal corpuscle 
The renal corpuscle (Figure 1c) is defined as the Bowman’s capsule together with 
the glomerular capillary tuft formed by branching of the afferent arteriole invading 
the capsule (Figure 1b, c) (4-6). 
1.1.1.2   Proximal convoluted tubule 
The epithelial cell layer lining the proximal convoluted tubule (Figure 1b) is 
connected by tight junctions that prevent waste products in the primary urine from 
re-entering the blood stream via the interstitial fluid. As approximately 180 liters of 
primary filtrate is produced daily and the final excreted volume of urine is only 
about one liter, the need of a highly effective tubular reabsorption mechanism is 
imperative. Also, apart from waste products, ions and solutes small enough to slip 
through the glomerular filtration barrier (GFB) are also present in the primary urine 
and need to be reabsorbed. For this function, the epithelial cell layer is covered 
with microvilli that increase its surface area and the number of associated active 
and passive transporters. The proximal tubule reabsorbs 100% of the glucose and 
amino acids from the glomerular filtrate, and about 70% of the sodium and water. 
The water is passively transferred into the hypertonic interstitium by osmosis (4-6).  
The part of the distal 
convoluted tubule called 
macula densa in close 
contact with the glomerular 
vascular pole forming the 
juxtaglomerular apparatus. 
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1.1.1.3. Loop of Henle 
The loop of Henle (Figure 1c) is the U-shaped portion of the tubule whose primary 
function is to recover salt and water from the urine. It consists of three different 
functional and distinguishable portions:  
 the descending limb  
 the thin followed by the thick ascending limb 
The thin descending loop of Henle receives the filtrate from the proximal tubule. As 
the medulla surrounding the descending limb is hypertonic water leaves the tubule 
by osmosis. Thus, at the bottom of the loop of Henle the fluid is highly enriched in 
salt and urea. When the tube, folding back on itself, again heads towards the 
cortex and becomes the thin ascending loop of Henle salt is passively diffusing into 
the medulla because of the higher salt concentration in the tubule than in the 
surrounding tissue.  If necessary, even more salt could be passed out into the 
medulla when the filtrate reaches the thick ascending limb because of the active 
salt transporters found here, making possible for more water to leave the 
descending limb by osmosis (4-6).  
1.1.1.4. Distal convoluted tubule 
In the distal convoluted tubule (Figure 1b, c), Na2+ is reabsorbed through the 
coupled secretion of H+ and K+ from the  tubular filtrate, which contributes to the 
regulation of the acid-base balance. The distal tubule is usually impermeable to 
water, but in the presence of antidiuretic hormone a further concentration of the 
urine is made possible.  At one point when the tubule loops back into the cortex, a 
region of the tubule called the macula densa (Figure 1b and c, Figure 3), comes in 
close contact with the glomerular vascular pole, thus forming the juxtaglomerular 
apparatus which is important in the control of systemic blood pressure and volume  
(7). The cells of the macula densa are able to relay the Na2+ concentration of the 
filtrate, a read-out of the systemic blood pressure status to the juxtaglomerular 
apparatus, which triggers various responses to adjust the pressure within the 
glomeruli accordingly (4-6). 
1.1.1.5. Connecting tubule  
In 2009 it was determined by using a Six2GFPCre transgenic mouse that the 
connecting tubule which fuses the nephron tubules and the collecting duct tips is 
derived from the cap mesenchyme and not as previously hypothesized from the 
ureteric bud, and should thus be regarded as a part of the nephron (8). 
1.1.2 Collecting duct system 
Several connecting tubule from adjacent nephrons merge to form cortical collecting 
tubules which then spill into descending cortical collecting ducts (Figure 1b), further 
down named the medullary collecting duct before entering the renal pelvis on its 
way to the ureter.  The collecting duct system participates in the regulation of 
electrolytes and due to the hypertonic medulla also further adds to water 
absorption (4-6).  
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1.2 NEPHRON DEVELOPMENT  
The renal primordial structures develop in a paired arrangement in the cervical 
region of the embryo, extending from the 4th to the 14th somite. They arise from the 
intermediate mesoderm and the development is divided up in three distinguishable 
stages; the pro-, meso- and meta-nephric stages (9) (Figure 2).  
 
Figure 2. The pro-, meso- and meta-nephric stages of the mammalian   kidney development. 
(Reprint with kind permission from Springer Link: Moritz et al.:Factors influencing mammalian 
kidney development: implications for health in adult life. Advances in anatomy, embryology, and cell 
biology 196: 1-78, 2008) 
1.2.1 Pro-nephric stage 
The pronephric stage appears in human at 3 weeks of gestational age (10). In 
mammals, it is located in a vestigial structure and consists of a set of paired 
tubules (the nephrotomes) spilling into a pair of primary ducts, which extends into 
the cloaca. The pronephros has no filtering or osmoregulatory function but is 
important for the induction of the next developmental stage, the mesoneophros (2) 
(Figure 2).  
1.2.2 Meso-nephric stage 
The disappearance of the pronephros and the formation of the mesoneophros take 
place around the 5th week of human gestation (10). As the pronephric ducts 
extends caudally in the embryo it induces the nearby intermediate mesoderm to 
develop into mesonephric tubules.  Each of the structures will get in contact with a 
tuft of the branching aorta. The tubules then encapsulate the capillaries and 
filtration of the blood is initiated. The filtrate is led through the tubules and drained 
into the continuation of the pronepric duct, now named the mesonephric or the 
Wolffian duct (2) (Figure 2). 
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1.2.3 Meta-nephric stage 
During the 6th week of human gestation the ureteric bud grows out from the 
mesonephric duct in the proximity to its attachment to the cloaca (10). Reciprocal 
interplay between the ureteric bud and the metanephric mesenchyme will induce 
the condensation of the metanephric mesenchyme leading to formation of the renal 
vesicle thus representing a mesenchymal to epithelial transition event. PAX-2 has 
been shown using gene knock-out technique to be essential for this conversion of 
cells of the metanephric mesenchyme to cells of the renal vesicle as in its absence 
no formation of the vesicle occurs (11). The cells of the renal vesicle are further 
divided up into two separate populations defined by their expression of FOXD1 and 
SIX1 respectively.  FOXD1 positive progenitor population will give rise to diverse 
cell types such as mesangial cells or angioblasts, whereas all the epithelial cell 
types of the nephron originate from the SIX1 positive cells (12).The cells of the 
vesicle are simple, polygonal vividly multiplying  and connected apically by tight 
junction proteins such as ZO-1 (13) but also desmosomal proteins (14). The renal 
vesicle which represents the earliest epithelial structure of the nephron then 
progresses through the comma, S-shaped and capillary stages of nephrogenesis 
(15) (Figure 3). The metanephric mesenchyme will in this manner contribute to the  
formation of the nephron while the ureteric bud constitutes the origin of the 
collecting ducts, renal calyces and urinary tract collection system (16). During the 
comma and S-shaped stages angioblasts within the metanephric mesenchyme 
starts to interact with the cell clusters and through paracrine signalling VEGF 
secreted from the non-matured podocytes attracts endothelial cell progenitors to 
migrate into the S-shaped body cleft (17, 18). The process of vasculogenesis 
matures further during the capillary stage. Now ZO-1 relocates from its apical to a 
basal region with the concomitant disappearance of desmosomal proteins (14, 19) 
and the presumptive podocytes start to establish their characteristic complex cell 
architecture with formation of foot processes and expression of slit diaphragm 
proteins such as nephrin (19), CD2AP (20) and podocin (21). Around this stage 
TDRD5 is also expressed constituting one of the anchor genes of the visceral 
epithelial cells at Theiler stage23 (15day dpc in mouse corresponding to day53 in 
human gestation) (22, 23). The process is finalized when the Bowman’s capsule 
encompasses the capillary tuft, together forming the renal corpuscle. WT-1 remains 
a podocyte specific marker throughout ontogeny and adulthood (24, 25), and 
dominant mutation of the encoding gene are associated with the Denys-Drash and 
Frasier syndromes (26, 27).  At 36 weeks of human gestation nephrogenesis is 
complete and each kidney has a full set of nephrons. 
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Figure 3. The progression through the meta-nephric stage of mammalian renal development. 
(Reprint with kind permission from Springer Link; Moritz et al.; Factors influencing mammalian 
kidney development: implications for health in adult life. Advances in anatomy, embryology, and 
cell biology 196: 1-78, 2008). 
 
1.3 RENAL CORPUSCLE 
The renal corpuscle is made up of the part of the nephron named the Bowman’s 
capsule and the glomeruli which is the capillary tuft it is invaded by. 
 
 
 
 
 
 
 
 
  
 
A Renal corpuscle 
B Proximal tubule 
C Distal convoluted tubule 
D Juxtaglomerular apparatus 
1 Basement membrane (basal lamina) 
2 Bowman’s capsule (parietal cell layer) 
3 Bowman’s capsule (visceral layer) 
3a-b  Foot processes (pedicels) 
4 Bowman’s space (urinary space) 
5a Mesangium (Intra glomerular cells) 
5b Mesangium (extra glomerular cells) 
6 Granular cells (juxtaglomerular cells) 
7 Macula densa 
8 Myocytes (smooth muscle) 
9 Afferent arteriole 
10 Glomerular capillary 
11 Efferent arteriole 
 
 
Figure 4.   The constituents of the renal corpuscle. 
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1.3.1 Bowman’s capsule 
The Bowman’s capsule is lined by a 0,1-0,3 µM  thick simple squamous epithelium 
made up of the fourth cell type of the renal corpuscle, the parietal epithelial  cells 
(28). The space enclosed by the parietal cell layer and the visceral epithelial cell 
layer (podocytes) is where the primary urine, also called the ultra-filtrate, is 
collected before being led out to the proximal tubule (29). The parietal cells that 
originate from the same SIX1 positive progenitor cells as the podocytes in the 
vesicle stage, diversify from the podocyte progenitor cells at the S-shaped stage 
(30). Transitional cells in the intersection between parietal cell and the podocytes 
have been seen in glomeruli which each express both parietal and visceral 
epithelial cell markers and are able to form foot processes onto Bowman’s 
basement membrane (31, 32). Others have proposed that a pool of the parietal cell 
population can, under some circumstances, migrate onto the vascular tuft and 
differentiate into podocytes (33, 34). These findings are interesting considering that 
the podocytes are terminally differentiated and unable to replenish in case of loss 
due to damage or senescence.  However, some investigations have shown this 
kind of repair as being maladaptive in itself causing albuminuria and 
glomerulosclerosis (35). 
1.3.2 Glomerulus 
A technique where glomeruli are transplanted into the anterior chamber of the 
mouse eye allowing for glomeruli in vivo imaging was recently developed (36). This 
and other techniques that allows for the study of the glomerulus in an in vivo 
setting will  add greatly to our understanding of this structure which is situated in 
the  Bowman’s capsule and contains a capillary tuft of five to eight trunks each 
subdivided further into 20-40 capillary loops (37).  After circulating through the tuft, 
the blood then exits through the efferent arteriole. A hydrostatic pressure is 
generated within the glomerulus (~60mmHg) due to its interposition between the 
afferent and efferent arteriole (38). However, due to the hydrostatic pressure in 
Bowman's space of ∼20 mmHg (39) plus the  afferent colloid osmotic pressure of 
25-35 mmHg, the effective filtration pressure is estimated to be ∼10 mmHg (40).  
The pressure may be varied by hormonal or neuronal cues that regulate the tonus 
of the smooth muscle properties of both podocytes and mesangial cells which are 
positioned on the blood and urinary side of the GBM, respectively (41). In this way 
the ultrafiltration of metabolic waste products and other small solutes such as 
water, glucose, amino acids, urea and sodium chloride is accomplished, while 
larger molecules such as albumin, immunoglobulins and plasma transport proteins 
are retained in the blood flow. As a measure of the permselectivity of the filter the 
sieving coefficient (Ɵ) is used, defined as the concentration of solute in Bowman’s 
space divided by concentration in the plasma (42). The filtrate represents about 
20% of the total plasma volume that enters the glomeruli at any given time. It 
passes through the fenestrated capillary wall, the basement membrane and the 
podocyte slit diaphragm before collected in the urinary space of the Bowman’s 
capsule (1, 29, 43-45).  
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1.4 GLOMERULAR FILTRATION BARRIER 
 
 
Figure 5. The glomerular filtration barrier, A. Endothelial cells. . Fenestrae. B. Glomerular basement 
membrane: 1. Lamina rara interna 2. Lamina densa 3. Lamina rara externa C. Podocytes: 1. Slit 
diaphragm associated proteins. 2. Filtration slit. 3. Diaphragm (Reprint from Wikipedia).                            
 
The glomerular filtration barrier (GFB) is considered as a size and charge selective 
molecular sieve between the blood flowing through the glomerular capillaries and 
the ultra-filtrate in the urinary space of the Bowman’s capsule (46), even though its 
charge selective properties has been debated (47).  Whichever, it  has the ability to 
filter massive amounts of water and small solutes into the Bowman’s capsule, while 
retaining at least 99,9% of albumin and other large proteins in the plasma (48). The 
classical description of the barrier composition is that of a three layers; the 
fenestrated endothelium of the capillaries, the superjacent glomerular basement 
membrane and finally the podocytes with the slit diaphragm spanning in-between 
the interdigitating foot processes (42). Additionally, an endothelial surface layer, 
referred to as glycocalyx (49-51), and the so called sub-podocyte space (40, 52) 
may be added to the list. It is apparent that these layers form a functioning entity 
that is dependent on the biochemistry, biophysics and cell biology of all its 
constituents (42, 45, 53). It has been shown that both genetic defects and/or 
acquired damage to any one layer may lead to proteinuria  (54-56), and the course 
taken in the progression of disease is highly variable and dependent on the 
etiology of the primary insult (57). 
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1.4.1 Endothelium  
Gene manipulation techniques targeting endothelial cells have generally been 
global, and thus not allowed specific targeting of glomerular endothelial cells. This 
has hampered studies on the biology of glomerular endothelial cells, as opposed to 
the podocytes and mesangial cells. It is however evident that the endothelium is a 
functional part of the GFB even though 20-50% of the glomerular capillary 
endothelial surface is occupied by 60-80nm in diameter wide trans cellular 
fenestrations (58). The large fenestrae are a prerequisite for the high permeability 
of fluid across the capillary wall, which is an order of magnitude higher than in any 
other systemic capillary beds (59).  The size of the fenestrae has previously 
diminished discussions the endothelium playing a functional part of the GFB as the 
openings are ~15x that of  a macromolecule such as albumin (42). However, 
several studies have shown that the endothelium does play an important part in the 
perm-selective properties of the GFB (56, 60, 61). For example, studies on the 
VEGF/VEGFR-2 signaling pathway between podocytes and glomerular endothelial 
cells have strongly supported that notion. Thus, it has been shown that albuminuria 
may be present in the case of a damaged endothelium without concomitant GBM 
or podocyte disturbance (62). Other investigators have also suggested that the 
level of proteinuria does not correlate with podocyte foot process effacement (63). 
The recent identification of a highly glomerular endothelium specific protein EHD3 
(64, 65) may provide new means to specifically target the glomerular endothelial 
cells in animals.  
1.4.2 Endothelial surface layer  
Using improved three dimensional electron microscopy techniques, investigators 
have generated images of a negatively charged glycocalyx bound to the luminal 
aspect of the endothelium covering and extending into the fenestrae (66, 67). It 
consists of covalently bound proteoglycans, glycoproteins and sialic acids 
produced by the endothelial cells that make up the core of this lattice, which in turn 
is associated with the long linear glycosaminoglycans of heparan sulfates and 
chondroitin sulfates. To this material circulating plasma molecules such as albumin, 
orosomucoids and lumican are adsorbed. Together, these components make up a 
200-400 nm deep endothelial surface layer (ESL) which may restrict passage of 
macromolecules based on both charge and steric hindrance (68, 69). Several in 
vivo and in vitro studies have been made on the role of the ESL as part of the 
permselective GFB barrier (70). It is surmised that damage of the ESL is a 
common denominator of diseases of the extrarenal vascular system and such 
diseases and  albuminuria often correlate to each other (71). It is a well-established 
fact that although diabetes is the most common cause of ESRD, most such 
diabetic patients also suffer from other forms of microangiopathies and 
macrovascular as well as cardiovascular complications before reaching this stage. 
Having identified a protein specifically expressed in glomerular endothelial cells 
(64) may enable conditional knockouts of genes expressed by those cells.  
 18 
1.4.3 Glomerular basement membrane 
The glomerular basement membrane (GBM) is a 250-400 nm thick specialized 
sheet-like extracellular matrix the components of which are produced and laid 
down by the adjacent endothelium and podocyte cells. Transmission electron 
microscopy of the GBM reveals a three laminar layer with the lamina rara interna 
and lamina rara externa facing the endothelium and podocytes, respectively, and 
an electron dense central layer, the lamina densa (72) (Figure 5B). The GBM has 
been proposed to contribute to the size and charge selective properties of the GFB 
(73-77), but it also constitutes the main structural support of the glomerular 
capillary wall. Harboring ligands for membrane proteins of podocytes, endothelium 
and mesangial cells, being in direct contact with each one of them makes it 
important also for the paracrine cell to cell signaling system of the different GFB 
constituents (78, 79). The GBM consists mainly of the macromolecules type IV 
collagen (80, 81), laminins (80, 82, 83), nidogen (84), and the heparan sulfate 
proteoglycans such as perlecan and agrin (85), which together produce an 
interwoven meshwork believed to impart the perm-selective  properties to the 
GBM.  
 Type IV collagen, the main structural component, is a trimer of α1 and α2 
chains (α1α1α2) in the embryo which is replaced after birth by α3α4α5 trimers (86). 
Mutations in any of the genes for the a3, a4 or a5 chains lead to distortion of the 
GBM structure and Alport syndrome which is characterize by hematuria and 
progressive glomerular disease that usually requires dialysis or transplantation 
treatments (87-89).  
 Laminins are large heterotrimeric glycoproteins made up of homologous α, β, 
and γ chains (90).  The laminin LN-511 (α5β1γ1) is the only GBM isoform in 
embryo, but it is replaced during GBM maturation by LN-521 (α5β2γ1) (91). 
Mutations in the LAMB2 gene lead to one form of congenital nephrotic syndrome 
referred to as Pierson syndrome (92, 93). It is speculated that the developmental 
switch between the laminin and collagen isoforms occur in order to make the 
mature GBM more resilient or aid the podocytes in their differentiation  (94). The 
glomerular diseases caused by type IV collagen and laminin gene mutations 
represent direct evidence that the GBM plays a crucial role in the glomerular 
filtration barrier.  
 Heparan sulfate proteoglycans (HSPG) contain a core protein with attached 
heparan sulfate (HS) chains. The HS moieties are negatively charged due to their 
repeats of sulfated disaccharides (sulfated glycosaminoglycan-GAGs) making up 
chains of unbranched polysaccharides. Basement membranes in general, and the 
GBM in particular, have a net anionic charge and HSPGs of the GBM such as 
perlecan, agrin (95) and collagen XVIII (96) are believed contribute to this negative 
charge. Perlecan, synthesized by the endothelium (97) which seems to be the  
most common HSPG in basement membranes in general, is less abundant in the 
GBM than agrin which is primarily produced by the podocytes (98). Since the work 
by Brenner and colleagues where they used differently charged dextrans to test to 
what extent they were able to cross the glomerular filtration barrier (99, 100) and 
the isolation of heparan sulfates from glomerular basement membranes by 
Farquhar and colleagues (101) it has been held in belief that these HSPGs play an 
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important role as providers of the GBM charge-selective properties. However, a 
mouse podocyte- specific deletion of agrin did not lead to any structural or 
functional defects of the glomerulus even though the negative charge of the GBM 
was greatly reduced (102). By targeting the perlecan encoding gene HSPG2 so 
that the attachment sites for the three HS chains were ablated did not have an  
effect on the filtering capacity of the mouse kidney, or the ultrastructure of the GBM 
(103). Furthermore, overall glomerular architecture and renal function was found 
normal in perlecan-HS/agrin double knock out mice (95)  suggesting that the 
proposed GBM negative charge is not so important as previously thought. 
1.4.4 Podocyte  
Multiphoton microscopy together with transgenic mice that express multicolor 
fluorescent proteins in the podocytes now allows for in vivo imaging of this cell 
(104) which is of a terminally differentiated, highly polarized and arborized parietal 
epithelial type located on top of the outer surface of the GBM (105). The size of a 
typical mouse podocyte with a main cell body area of ~50 µm2, and the length of 
the primary and secondary foot processes in the several µm and  µm range 
respectively depict an extraordinary type of cell with extraordinary needs (106). 
1.4.4.1 General structure 
From the voluminous cell body floating aloft in the urinary space extend several 
primary and secondary processes which extensions, referred to as foot processes 
attached to the outer surface of the GBM (106). The foot processes (also termed 
pedicels), interact in an interdigitating fashion with foot processes of a neighboring 
podocyte. The podocytes are highly polarized cells with basal and apical 
membrane surfaces which are well defined by the baso-laterally inserted slit 
diaphragm (SD) (105). Microtubules and intermediate filaments like vimentin and 
desmin span longitudinally the major processes, whereas contractile actin filaments 
are critical components of the foot processes (107). The foot process actin 
filaments, interconnected by α-actinin- 4 (108) are linked via proteins like CD2AP 
(109), NCK1 (110, 111) and podocin (112, 113) to components of the SD such as 
nephrin and NEPH1. The podocyte cell body is densely packed with organelles 
where the nucleus is prominent and endoplasmic reticulum, Golgi and mitochondria 
are well developed and abundant, witnessing of a high metabolic activity (105, 
114). 
1.4.4.2 Function 
The podocytes are an archetypal example of a cell type with a morphology 
uniquely tailored to fit its highly specialized functions.  Its shape is dependent on 
the dynamics of the underlying cytoskeleton, which regulation seems to be focused 
around the slit diaphragm (115, 116). The foot processes with their structure of 
filamentous actin bundles and subcortical actin meshwork provides anchor-points 
for the SD, as well as providing the framework for the propagation of outside in 
signaling cues from SD proteins to the endothelial cells (indirectly through the 
GBM) and directly to the mesangial cells (at the intersection between the capillary 
and the mesangium) (110, 111, 117-119). Together with the endothelial cells they 
 20 
also synthesize the GBM components of the heterotrimeric laminin-1 ( 1, 1, and 
1 chains) and laminin-11 ( 5, 2, and 1 chains) throughout glomerular 
development (91), as well as the collagen α3 α4 α5 (IV) network (81). They induce 
vasculogenesis and fenestrae formation of endothelial cells through the secretion 
of the pro-angiogenic factors vascular endothelial growth factor (VEGF)-A and 
angiopoetin-1 (120-122). They have been found to endocytose filtered albumin 
(123) and immunoglobulins (124). The mesangial cells have by tradition been 
regarded as the pericytes of the glomerulus referring to their smooth muscle 
activity in modifying glomerular filtration in response to vasoactive agents. 
However, podocytes have lately been shown to contract in vivo in response to 
elevated intracellular [Ca2+] leading to a reduction in capillary diameter (125-127). 
A study that showed differentiated podocytes to possess contractile properties in 
vitro also localized the smooth muscle markers smoothelin and calponin and the 
specific transcription factor myocardin to differentiated podocytes both in vivo and 
in vitro (128). Due to shared morphological traits (105, 129) and molecular make up 
(23, 64, 130-132) the podocytes are often compared to the neurons (133). As an 
ultimate manifestation of the podocytes neuronal properties they have been found 
to communicate intercellularly through synaptic transmission (134-136). To prevent 
the GFB from clogging the podocytes have also been hypothesized to take part in 
its back-washing, by means of the sub podocyte space (40, 68, 69, 137). 
    
1.4.5 Sub podocyte space 
The sub podocyte space was first described in 1950 by Gautier and colleagues 
(138) but as the further investigation of the structure required three dimensional 
reconstruction of fragile, sub-microscopic  (<1µm) formations, it was not until the 
beginning of the millennium that it could be more closely described using serial 
section transmission electron microscopy (137), and later also described under 
physiological relevant conditions (40). Using Serial Block Face Scanning Electron 
Microscopy, it was found that 50-60% of the GFB was covered by the SPS in rat 
glomeruli (69). The SPS is defined as “a space on the urinary side of the GBM that 
is bound by the GBM and the foot processes on one side and the underside of the 
podocyte cell body, process, or membrane on the other” (137). From the SPS the 
filtrate is passed out through Sub-Podocyte space Exit pores (SPE) that drains into 
the Inter Podocyte Space (IPS) which is a narrow space in-between the podocyte 
cell bodies at the center of the glomerulus (137, 139). The filtrate is then passed 
out through this labyrinthine system out to the periphery of the glomeruli where it 
drains into the classical Bowman’s space.  Calculations have shown that the SPS 
together with a regulated SPE circumference is able to confer resistance to the flux 
of glomerular filtrate similar to or even greater than the resistance applied by the 
underlying GFB (40, 137). The physiological significance remains to be elucidated 
but its speculated that the podocyte in this way is able to sense the rate of filtration 
which it then reacts upon. It may also serve in backwashing the GFB to prevent its 
clogging or as a mean of modifying the primary filtrate (40, 68, 69, 137).  
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1.4.6 Slit diaphragm (see 1.5) 
1.5 SLIT DIAPHRAGM 
 
 
 
The first description of the slit diaphragm as imaged by Rodewald and Karnovsky 
in 1974 using electron microscopy on mouse and rat kidney tissue was that of a 
iso-porous zipper-like substructure, spanning the ~40nm wide slit between 
neighboring foot processes (140). It was seen to have alternating, periodic cross 
bridges extending from the baso lateral podocyte plasma membranes to a central 
filament running parallel to and at equal distances to the cell membrane. The 
physiological data indicated that the diaphragm would hinder the filtration of 
proteins at the size of serum albumin an larger (140). This physical description of 
the diaphragm has however been questioned with the advent of improved imaging 
techniques with one of the studies instead propose it to be of a heteroporous 
composition (141). The inter cellular part of the slit diaphragm is believed to 
consists of nephrin and NEPH1 which belongs together with the highly related 
NEPH2-3 to the NEPH1-related family of proteins (142). Their extracellular 
domains are proposed to form homo- and hetero-oligomeric receptor complexes 
associating via cis- and trans- interactions (142-145). The transmembrane portions 
of nephrin and NEPH1 spans the plasmalemma at sites of cholesterol rich micro 
domains where podocin also resides, a protein which is believed to be necessary 
for the recruitment of nephrin and NEPH1 as well as other slit membrane 
associated proteins to these lipid rafts for the assembly of the slit diaphragm 
complex (146, 147). This slit diaphragm nephrin-NEPH1-podocin complex in turn 
assembles a specialized signaling protein cluster of various phosphorylation/ 
adaptor/ effector proteins for the transmission of outside-in information to the actin 
cytoskeleton (111, 118, 142, 148-152).  
Below follow a description of SD- or SD associated proteins that through forward 
genetics of human renal disease or through genetic targeting in animal models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  A sketch of the slit diaphragm (SD) with a selection of SD- and 
SD- associated proteins. 
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(reverse genetics) has shown to be crucial for SD formation or SD- signaling to the 
actin cytoskeleton of the podocytes. 
1.5.1 Nephrin 
The cloning of nephrin (153) and its subsequent localization to the slit diaphragm 
was a milestone in glomerular research (154, 155). NPHS1, the gene encoding 
nephrin is mutated in the autosomal-recessive disease congenital nephrotic 
syndrome of the Finnish type (153). The disease is mainly found in the Finnish 
population with an incidence of ~1 in 10,000 newborns (156), and arises due to the 
mutated or truncated NPHS1 protein product leading to massive nonselective 
proteinuria already in utero (153). Nephrin is an 180kDa type-1 transmembrane 
glycoprotein of the immunoglobulin superfamily with eight Ig-like domains and a 
fibronectin type III (FNIII) domain extra cellularly, a transmembrane part, and a 
small intracellular C-termini (153). Two nephrin molecules are believed to 
assemble through homophilic head-to-head interactions across the slit forming a 
zipper like arrangement (154), much like the structure that was described by 
Rodewald and Karnovsky (140).   
 It has been shown that nephrin signaling is dependent on interaction with 
podocin located in lipid rafts (157), and nephrin localization to the lipid rafts is 
disrupted in mutations in NPHS2, the podocin encoding gene (146). The 
extracellular domain of nephrin also associates with NEPH1 in both cis- and trans- 
interactions (143-145). Nephrin signaling is orchestrated through the 
phosphorylation of crucial tyrosine residues within its cytoplasmic domain by 
kinases such as FYN (118) and phosphatidyl-insositol-3- kinase (150) and others 
(111, 148, 149, 151, 152), leading to recruitment of cytoskeletal adaptor proteins 
such as NCK1/2 via their SH2 domain (110, 111, 119)  in turn controlling actin 
polymerization through N-WASP (158) and the p21 activated kinase 
serine/threonine kinase PAK (159). Phosphorylation of tyrosine residues in the 
nephrin C-terminus also recruits the regulatory SH2 domain of PI3 kinase p85 
subunit, in turn, recruiting and activating the PI3 kinase p110 catalytic subunit 
(152), which converts the membrane lipid phosphatidylinositol-4, 5-biphosphate 
(PIP2) to phosphatidylinositol-3, 4, 5-triphosphate (PIP3) at the plasma membrane. 
PIP3 phospholipids form docking sites for the serine/threonine kinase AKT (160) 
leading to increased AKT activity and reduced cell death (152). Nephrins 
involvement in actin regulation is also is depicted by its interaction with CD2-
associated protein (CD2AP) (112) which is a protein important for cytoskeletal 
maintenance and cell morphology (161, 162). Furthermore nephrin binding to IQ 
motif containing GTPases activating protein (IQGAP) activates the small GTPases 
RAC1 and CDC42 and their subsequent recruitment of ARP2/3 complex and 
formin-dependent actin polymerization components (163).  
 The high conservation of nephrin and NEPH1 through evolution is reflected in 
their role in the formation of skeletal muscle in drosophila where they drive the 
myoblast fusion through the interaction between nephrin drosophila homologues 
hibris and sticks-and-stones on founder cells with NEPH1 homolog dumbfounded 
on fusion competent cells (164-166). Moreover, in drosophila the process of eye 
development is strictly regulated by interactions between nephrin homologue hibris 
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expressed on primary pigment cells and NEPH1 homologue roughest on 
neighboring inter-ommatidial precursor cells. The eyes of hibris and roughest 
mutant flies get a “rough” appearance as the inter- ommatidial precursor cells are 
misplaced and form aberrant junctions (167, 168). Another example of nephrin and 
NEPH1 conserved roles in guiding cells to make appropriate interactions is in C. 
elegans where nephrin and NEPH1 homologs SYG-2 and SYG-1 respectively are 
expressed in neighboring heterologous cell types where they make trans 
interaction (169-171). Their expression is essential for guiding motor neurons to 
form synapses with their appropriate target cells (170, 172, 173) 
1.5.2 Podocin 
NPHS2 was discovered as a gene mutated in about 20% (174) of patients with 
early-onset steroid resistant focal segmental glomeruli sclerosis (175). Genetically 
targeted mice in which podocin was deleted or expressed with missense mutations 
were present with albuminuria at birth and died within a few weeks (176, 177). 
Progressive decline in glomerular function and elevated histo- pathological lesions 
were noted in mice where podocin was deleted in a podocyte specific manner 
using Cre-loxp technology (178). The NPHS2 encoded protein podocin which 
expression is restricted to the podocytes (24, 25, 179) and Sertoli cells of the testis 
where it is hypothesized to have a role in the blood/testis barrier (180), is a 42kDa 
integral molecule belonging to the stomatin family of proteins containing the 
cholesterol binding domain prohibitin (181). It has a hairpin-like structure anchored 
to the membrane via its central part and with both N- and C-terminus facing the 
cytosolic side of the slit diaphragm (175). Podocin accumulates as oligos in lipid 
rafts that are highly defined micro domains dominated by sphingolipids and 
cholesterol (112, 182). Podocin direct interaction with nephrin is necessary for 
nephrin signaling  (157), and mutations in Nphs2 disrupts nephrin localization to 
the lipid rafts (146). Sub- cortically of the rafts an electron-dense, Triton-X resistant 
material is found, composed of a highly branched actin cytoskeletal network, a 
region remarkably reminiscent of the Post-Synaptic Density (PSD) of the neurons 
(113).  The C. elegans podocin homologue mechanosensory protein 2 is believed 
to link the mechanosensory channel and the microtubule cytoskeleton of the touch 
receptor neuron, and it has been suggested that podocin also acts as such a 
mechanosensor which enables the podocyte to remodels its cytoskeleton and 
contract the foot processes as a response to mechanical stimuli through its 
activation of TRPC6, a Ca2+ channel, thus increasing cytosolic Ca2+ levels 
regulating actin cytoskeleton polymerization (183-185). 
1.5.3 CD2AP 
CD2-associated protein (CD2AP) was originally identified as an interaction partner 
of the mouse T-cell membrane protein CD2 where it is involved in the clustering of 
CD2 and T-cell polarity (186). It is a 70kDa multidomain scaffolding protein in the 
kidney primarily expressed in the podocytes (109, 112, 187, 188), where CD2AP 
directly interacts with the cytoskeletal protein filamentous actin (f-actin) (189, 190) 
and the actin-bundling protein synaptopodin (191) as well as nephrin (109), 
podocin (112) and RAC1 (162), thus serving as a linker anchoring slit membrane 
 24 
proteins to the actin cytoskeleton. In human mutations in the CD2AP gene results 
in FSGS  (192-195), and mice deficient in CD2AP develop mesangial sclerosis and 
die at 6-7 weeks of age due to renal failure  (109). 
1.5.1 α-actinin-4 
The alpha actinins belongs to the spectrin gene superfamily, which represents a 
diverse group of cytoskeletal proteins (196). The gene ACTN4 gene encodes a 
~100kDa cytosolic nonmuscle, alpha actinin isoform that is necessary for the 
cross-linking and accurate actin turnover of the podocyte stress fibers (108). 
Mutations in the human ACTN4 gene cause an inherited autosomal-dominant form 
of FSGS  (197), and in mice three identified miss sense mutations within exon 8a 
produced an α -actinin-4 protein with a pathological increased affinity for actin,  in 
which study it was also shown that even though α-actinin-4 has an ubiquitous 
expression pattern histological examination of the mice only showed kidney 
abnormalities (108, 198) highlighting the necessity of tight regulation of the 
podocyte actin cytoskeleton. 
1.5.2 TRPC6 
TRPC6 belongs to a family of six human nonselective Ca2+ permeable cation 
channels which are widely expressed in the vertebrate tissue  (199). In podocytes it 
localizes to the foot processes in the vicinity of the SD but also in the cell body and 
throughout the major processes (200). Nominally functional TRPC channels are 
tetramers composed of six transmembrane segments with both NH2 and COOH 
termini facing the cytosol (199). The activation of TRPC members is believed to be 
initiated by cascades involving phospholipase C hydrolysis of phosphatidylinositol-
4,5-bisphosphate (PIP2) liberating diacylglycerol (DAG) and inositol1,4,5-
trisphosphate (IP3) (201). Several gain of function mutations has been mapped to 
the cytosolic terminal end of TRPC6 in families with a late onset autosomal 
dominant form of FSGS (200, 202, 203). Similar to human glomerular disease 
caused by mutations in CD2AP and ACTN4 respectively the TRPC6 mutations is 
not generally present with any other pathological phenotype which is remarkable 
as all three expressions are widely distributed to other tissues (191, 197, 204, 205). 
The importance of a tight Ca2+ regulation was also highlighted in a study where the 
up regulation of wild-type TRPC6 was seen in patients suffering from acquired 
human proteinuric kidney diseases as well as in experimental models of acquired 
glomerular disease (183). In a study where the relationship between TRPC-
mediated calcium entry and cytoskeletal shape and rigidity in podocytes was 
investigated it was found that calcium influx was mediated by angiotensin II 
through both TRPC5 and TRPC6 channels. Downstream however it was seen that 
TRPC5 signaled through RAC1 to promote cell motility, whereas TRPC6 signaled 
through RHOA to inhibit it (206). The tight antagonistic regulation between RAC1 
and RHOA seems as a prerequisite for a normal podocyte phenotype and 
dysregulation thereof leads to podocytopathy exemplified with the over activation of 
RHOA in families with gain-of-function mutations in TRPC6 (202, 206). Accordingly 
mice lacking TRPC6 infused with angiotensin II were significantly less albuminuric 
than the infused wild- type control (207). In line with our study where the tight 
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regulation by RHPN1 of RHOA dependent stress fiber formation is necessary for 
healthy podocytes (208) Wang et al. reports that both RHOA activation and 
inhibition caused albuminuria and foot process effacement  (209). Furthermore Zhu 
et al. reports that inducible activation of RHOA in mice leads to FSGS in a dose 
dependent manner (210). Thus, compiling data seems to implicate that TRPC6 
expression and intracellular calcium levels must be tightly regulated to avoid 
aberrant RhoGTPase activity. 
1.5.3 NCK1/2 
NCK1 and NCK2 are two highly related proteins (211) composed of the 
phosphotyrosine- interacting SH2 and SH3 domains with which they can recruit 
various other proteins involved in the regulation of actin assembly, such as the 
NCK1 SH2 domain binding to tyrosine-phosphorylated binding sites of nephrin 
(110, 111) and its SH3 domains on the other hand binding to neuronal Wiskott-
Aldrich syndrome protein (N-WASP) (110, 111), whereby N-WASP activates the 
ARP2/3 complex and cortactin linking the nephrin-NCK complex to the actin 
cytoskeleton (115, 161). NCK recruitment to phosphorylated nephrin is initiated 
during development, injury or repair when cytoskeletal reorganization and rapid 
actin polymerization is required (111). Mice deficient of both NCK1 and NCK2 in 
podocytes develop nephrotic range proteinuria, in addition to ultra- structural 
changes in glomeruli similar to those found in human end-stage renal disease 
(110). 
1.5.4 FAT1 
The 500-kDa FAT1, a protein that belongs to the protocadherin superfamily is 
localized to the slit area where it has been found to co localize with nephrin and 
ZO-1 (212).  Newborn FAT1 null mice display effaced foot processes without slit 
diaphragms and die within 48 hours (213). It is believed that FAT1 takes part in the 
generation of the necessary intercellular adhesion framework between foot 
processes while at the same time maintaining the junctional distance.  In support of 
this is the involvement of FAT1 in actin dynamics (214) and the active re-
arrangement of actin cytoskeleton during progression of podocytopathy (215, 216).  
1.5.5 MAGI-2 
MAGI-2, member of the membrane associated guanylate kinase (MAGUK) family 
of scaffolding proteins is highly expressed in the synaptic junctions of mouse brain 
(217, 218) and glomerular podocytes (219). Through its PDZ, WW, and GUK 
domains it acts as a scaffolding protein coordinating signaling complexes (220-223) 
and has been identified as an interaction partner of nephrin, IQGAP and CASK in 
rat glomeruli (224). Magi-2 null mice present with early-onset, progressive 
proteinuria and non-inflammatory, proliferative glomerulopathy with collapsing and 
crescent-like characteristics within a few weeks after birth. The pathological 
process coincides with decline of nephrin expression and the upregulation of 
CIN85 (225) which is a protein regulating the turnover of slit diaphragm complex 
proteins (226).  
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1.5.6 PLCɛ1 
PLCɛ1 is a lipase cleaving phosphatidylinsositol-4,5-bisphosphate (PIP2)  to the 
second messengers inositol1,4,5-triphospahte (IP3) and diacylglycerol (DAG) (227) 
and is thus involved in intracellular signaling pathways. It plays an important role in 
Ca2+ release both from internal stores as well as influx from cat ion channels such 
as TRCP6 (228).  In the podocytes it is has been identified from the early S-shaped 
stage and is highly expressed in both cell body and foot processes at the late 
capillary stage (229). Even though PLCɛ1 null mice do not display a renal 
phenotype  (230) positional cloning has identified PLCɛ1 in families with early 
onset nephrotic syndrome and ESRD, histopathologically displaying diffuse 
mesangial sclerosis and FSGS and histochemistry showing reduced nephrin 
expression (229). The importance of PLCɛ1 for the integrity of the filtration barrier 
has also been described in zebrafish where PLCɛ1 anti sense morpholino knock 
down and subsequent injection of a 500-kD Dextran labeled FITCH tracer molecule 
into the blood stream showed FITC-positive endocytosed vehicles in the epithelial 
cells of the pronephric tubule (229). PLCɛ1 is an exception to the general trend 
where mutated genes causing FSGS are most often structural components of the 
podocytes. 
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1.6 OVERVIEW GLOMERULOPATHY 
Renal disease is not one disease but a generic term describing the inability of the 
kidneys for one reason or another to excrete wastes and maintain the electrolyte 
balance. Even when narrowing down the focus to the filtering unit itself, the 
glomerulus, now describing the disease as ”glomerulopathy”, the etiologies are 
diverse even if the disease commonly manifests as proteinuria.  Most often 
“glomerulopathy” implies a non-inflammatory condition whereas the term 
“glomerulitis” is used when inflammation is involved. As the filtration barrier 
composes the integral part of the glomerulus, glomerulopathy often implies a 
malfunctioning interplay for one or another reason between the constituents of the 
GFB, and the disease can be primary due to gene mutations or pathogens, but it 
may also be secondary to other conditions such as hyperglycemia and 
hypertension. Genetic mutations leading up to primary disease can be monogenic, 
recessive or dominant, or they can be polygenic where the disease arises as a 
combined effect of mutations in two or more genes. As monogenic diseases, 
contrary to polygenic ones, have a tight genotypic-phenotypic relationship with 
almost always “full penetrance” (clinical symptoms are present in all individuals 
who have the disease-causing mutation) forward genetic studies of such human 
renal disease causing mutations giving rise to an observed phenotype has 
contributed greatly to our knowledge of GFB composition. Therefore, the presented 
chart (see page 28) that gives an overview of human glomerular disease causing 
mutations is focused on such monogenic diseases. 
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2 AIMS OF THE STUDY 
 
The aims of this study were to increase current knowledge of the glomerular 
filtration barrier in health and disease by studying novel components, gene 
regulation and cellular aspects. 
 
The specific objectives were:  
Paper I:  Examination of the expression and role of TDRD5 in podocytes with 
emphasis on the transcriptional and protein levels using in vivo as well as in vitro 
methods.  
 
Paper II: Determination of the global expression signature of renal glomeruli during 
progression of Adriamycin-induced nephropathy in mice using RNA sequencing. 
 
Paper III: Characterization of a novel podocyte specific protein Rhophilin1 and its 
function in the maintenance of the actin cytoskeleton in mouse podocytes.  
 
Paper IV: Further studies on the effect of a single nucleotide polymorphism (SNP) 
r1866813, on differential expression of NCK1 the gene of which has been 
genetically associated with diabetic nephropathy. 
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3 EXPERIMENTAL PROCEDURES 
 
The methods used in papers I-IV are described in detail in respective Material and 
Methods sections. 
3.1 ANTIBODIES  
Table 1. Primary antibodies used. 
(Alexa Fluor secondary antibodies (Life Technologies) were used in addition).  
 
 
 
 
  
Antibody Product nr Company Study 
β-actin ab8227 (rabbit) Abcam [I,III, IV] 
c-myc M4439 (mouse) Sigma-Aldrich [III] 
c-myc C3956 (rabbit) Sigma-Aldrich [I, III] 
dendrin (64) (rabbit)  [III] 
f-actin (rhodam.-phallod.)  Life Technologies [III] 
GFP A11122 (rabbit) Invitrogen [III] 
HIC5  
 
611164 (mouse) BD transd. laboratories [III] 
IL-20rb ab95824 (rat) Abcam [IV] 
NCK1 Ab32120 (rabbit)  Abcam [IV] 
NPHS1 BP5030 (guinea pig) Acris GmbH [III] 
p-Myosin Light Chain 2 3675 (mouse) Cell Signaling Techn. [III] 
NPHS2 p0372 (rabbit) Sigma-Aldrich [I] 
RHPN1 sc-1940 (goat) Santa Cruz [III] 
RHPN1 SAB1408228 (mouse) Sigma-Aldrich [III] 
RHPN1 (208) (rabbit)  [III] 
STAG1 #A300-157A(goat) Santa Cruz [IV] 
SYNPO sc-50459 (rabbit) Santa Cruz [III] 
TDRD5 HPA014563 (rabbit) Atlas Antibodies [I] 
TDRD5 HPA029418 (rabbit) Atlas Antibodies [I] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Antibodies may be monoclonal or polyclonal. 
Monoclonal antibodies bind to the same epitope as they are derived from identical immune cells. 
Polyclonal antibodies are derived from several different immune cells and react with different epitopes. However, most 
often the host is immunized with a sequence of the target protein fused to a “tag”- sequence that allows for affinity 
purification of the produced antibodies giving rise to monospecific antibodies.  
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3.2 BLOOD UREA NITROGEN ANALYSIS (BUN) [II] 
As a measurement of glomerular filtration rate and thus renal health the assay 
measures the level of the metabolic waste product urea. BUN was quantified using 
QuantiChrom Urea Assay Kit (BioAssay System), which uses a chromogenic 
reagent that forms a colored complex specifically with urea. The color intensity is 
directly proportional to the sample urea concentration. The assay was used as a 
quantification of glomerular disease progression in Adriamycin injected mice [II]. 
3.3 CONFOCAL MICROSCOPY [III] 
Confocal microscopy is an imaging technique allowing for increased optical 
resolution and contrast of a micrograph by the addition of a pin-hole at the confocal 
plane of the lens to eliminate out-of-focus light. A reconstructed three-dimensional 
image is then assembled from the sampled images. The technique was used in III 
to image immuno-fluorescent cells and kidney samples.  
3.4 CREATININE ASSAY (SERUM/ URINE) [II, III] 
Creatinine is synthesizes from creatine, which is produced during muscle 
contraction at a fairly constant rate. Creatinine is removed from the blood by 
filtration in the glomerulus and excreted in the urine.  When glomerular filtration 
rate is lowered due to kidney disease blood creatinine levels are increased, and 
urinary levels are diminished. Serum creatinine levels were measured 
(QuantiChromTM Creatinine Assay Kit (BioAssay Systems, Hayward, CA) using 
picrate that forms a red colored complex with creatinine which was subsequently 
quantified. The assay was used in papers II and III to evaluate urine and serum 
creatinine levels respectively in mice. 
3.5 ELECTRON MICROSCOPY (SCANNING (SEM) / TRANSMISSION (TEM)) [I, 
II, III] 
An imaging technique that uses scattered (SEM) and transmitted (TEM) electrons 
respectively as a source of illumination. They differ in application as SEM focuses 
on the sample’s surface creating a 3D-image whereas TEM provides the details 
about internal composition requiring thin sections of the sample.  As the electron 
wavelength is 100,000 times shorter than that of photons, it has a higher resolving 
power than light microscope.  TEM was used in papers I, II, and III to 
ultrastructurally determine the morphology of sectioned zebrafish  [I], and mouse 
glomeruli  [II, III], whereas SEM was used in III to visualize the surface of the 
mouse glomerular tuft. 
3.6 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) [II, III] 
Enzyme-linked immunosorbent assay (ELISA) is a biochemical method used to 
detect and quantify substances such as albumin in biological samples. In an 
ELISA, the antigen of interest is immobilized to a solid surface and then complexed 
with an enzyme-linked antibody. Detection is accomplished by incubating with a 
substrate that the enzyme will convert to some detectable signal, most commonly a 
color change that may be quantified. A so called competitive version (Albuwell, 
Exocell) of the method was used in II and III to quantify urinary albumin where 
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albumin of the stationary phase and albumin of the urine sample were competing in 
the binding to added anti-albumin antibodies. After washing only the albumin 
bound antibody that was bound to the stationary phase remained in the well. 
Detection was accomplished by the addition of anti- IgG -HRP conjugate and a 
chromogenic substrate that was oxidized by the horse radish peroxidase (HRP) 
producing a color of a quantifiable intensity. 
3.7  ETHICS STATEMENT [I, II, III, IV] 
All the experimental studies presented were conducted according to regulations 
related to handling of laboratory animals and approved by local ethical committees. 
3.8 FLUORESCENCE-ACTIVATED CELL SORTING (FACS) [I, III] 
A method for sorting a heterogeneous mixture of cells based on the light scattering 
or fluorescent characteristics of the cells. In brief, the cells are suspended in a 
stream of fluid whereby they are passed through a fluorescence measuring station 
after which a charge is applied to the molecules based on their fluorescence 
intensity. The charged droplets are then fractionated based on their charge. The 
method was used in papers I and III where total glomerular cell populations from bi-
transgenic mice were fractionated.  
3.9 GLOMERULI ISOLATION [I, II, III, IV] 
A technique developed at Göteborg University by Dr Minoru Takemoto (231) where 
glomeruli is isolated from mouse kidney by perfusion though the heart using 
spherical super-paramagnetic Dynabeads (Ø 4.5 μm). The magnetic beads get 
stuck in the glomeruli which can be collected using a magnet. The large amount of 
RNA subsequently extracted from such glomeruli was a prerequisite for papers I, II, 
III and IV. 
3.10 HISTOCHEMISTRY [I, II, III] 
This is a technique that uses biochemistry to visualize the morphology of cells and 
tissue. 
3.10.1  Hematoxylin/ eosin staining (HE) [I, II] 
 Hematoxylin stains nucleic acids (deep-purple) whereas eosin stains proteins 
(pink) nonspecifically. The method was used in I to investigate the morphology of 
the zebrafish pronephros in tdrd5 mutants. In II it was used to investigate the 
morphology of kidney sections of Adriamycin-injected nephrotic mice.     
3.10.2 Periodic acid-Schiff staining (PAS) [III] 
Periodic acid–Schiff staining is a method that is used to detect carbohydrates such 
as polysaccharides, glycoproteins and glycolipids and is therefore often used to 
stain structures containing a high proportion of these macromolecules such as 
connective tissue and basal lamina. The periodic acid oxidizes diols of the sugar 
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into aldehydes. The method was used in paper III to visualize the morphology of 
mouse kidney tissue from Rhpn1-/- mice.  
3.11 IMMORTALIZED HUMAN PODOCYTE CELL CULTURE [III] 
Terminally differentiated podocytes do not maintain their unique phenotype in cell 
cultures. However, it is possible to extensively maintain the podocyte properties in 
cell culture using an immortalized podocyte line. A human immortalized podocyte 
cell line used in III  was generated by transfection with the temperature-sensitive 
proto-oncogene SV40-T (232) which makes the cell to proliferate at the permissive 
temperature 33 0C. The SV40-T gene is then turned off after moving the cells to the 
non-permissive 37 0C whereby they enter growth arrest and take on more podocyte 
characteristics. In III we used the cell line to investigate RHPN1 effect on the 
podocyte actin cytoskeleton. 
3.12 IMMUNOFLUORESCENCE STAINING [III, IV] 
Both direct and indirect immunofluorescence staining methods were used in III and 
IV.  DAPI (4', 6-diamidino-2-phenylindole) which is a fluorescent stain that binds A-
T rich regions in DNA was used to image nucleus in a direct way. Phallodin 
conjugated to the red-orange fluorescent dye tetramethylrhodamine was used to 
image filamentous actin. Other proteins of interest were imaged indirectly by 
incubation with IgG-conjugated fluorophores (Alexa Fluor Dyes, Life Technologies) 
which targeted protein specific primary antibodies. The technique was used on 
cells [III] and on kidney section [III, IV]. 
3.13 IMMUNOGOLD ELECRON MICROSCOPY [I] 
A staining technique used with transmission electron microscopy where colloidal 
gold is attached to antibodies designed to cross-react with specific proteins. The 
technique was used in paper I where TDRD5 was found to be localized to 
podocytes in human kidney sections. 
3.14 IN SITU HYBRIDIZATION [I] 
In situ hybridization is used for localization of mRNA transcripts in situ using its 
corresponding antisense sequence as a labeled RNA probe. The method was used 
in I where Digoxigenin (DIG) conjugated to uridine (Roche Applied Science) was 
incorporated into RNA using RNA polymerase. The riboprobe then hybridizes to 
the sense mRNA on snap frozen mouse kidney sections facilitating its detection 
using a DIG-antibody conjugated to alkaline phosphatase whereby it was 
visualized using NBT and BCIP. 
3.15  LUCIFERASE ASSAY [IV] 
The Dual-Luciferase® Reporter Assay System (Promega) allows for the 
quantification of the ability with which a sub cloned sequence activates the firefly 
(Photinus pyralis) luciferase reporter sequence. A vector carrying the Renilla 
(Renilla reniformis) luciferase reporter gene is co transfected acting as an internal 
control. The system was used in IV as a mean of investigating the ability of the 
different cis-acting SNP at the 3q locus to activate the expression of NCK1. 
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3.16 MOUSE GENE TARGETING TECHNIQUE [III] 
A reverse genetic technique that awarded Mario R. Capecchi, Sir Martin J. Evans 
and Oliver Smithies The Nobel Prize in Physiology or Medicine 2007. The method 
is based on the transfer of a DNA sequence which is homologous to the 
endogenous mouse gene to be targeted except for a desired mutation and with the 
addition of a selection cassette into stem cells isolated from a mouse blastocyst 
(white mouse). Through homologous recombination the introduced sequence will 
occasionally be incorporated into the genome. Cells are grown in selective media 
and cells in which incorporation of the introduced sequence has taken place will be 
able to expand due to resistance conferred by their selection cassette. Such cells 
are analyzed using Southern Blot to confirm that the recombination has occurred in 
the desired location. Clones of correctly targeted cells are then introduced into a 
blastocyst (black mouse) and implanted into a pseudo pregnant female.  The 
resulting pups will be chimeras (black/white). In some of the chimera the mutation 
may be transmitted to the germ cells producing sperm and eggs with the mutated 
gene. When such chimeras are crossbred with wild type mice some of the offspring 
will have one copy of the knocked-out gene in all their cells (white mice), but they 
are still heterozygous. Interbreeding of these heterozygous offspring will produce 
some mice that are homozygotes of the mutation. The technique was used to 
produce an Rhpn1 knock out mouse [III] in which exons 1-4 of the Rhpn1 gene 
were substituted with a Green Fluorescent Protein (GFP) cassette. 
3.17 PHASE CONTRAST MICROSCOPY [III] 
An optical microscopy technique that converts the phase shifts of light passing 
through a transparent media into brightness changes of the image. The 
microscope was used in III to visualize isolated glomeruli. 
3.18 PLASMIDS AND CLONING [I, III, IV] 
A plasmid is a small circular DNA molecule that within biotechnology is used for the 
cloning and amplification of DNA sequences through the transformation (into 
bacteria) or transfection (into mammalian cells) whereby the endogenous 
replication machinery is used for the amplification into a desired amount of copies. 
The technique was used in I to amplify both Tdrd5 full length transcripts cloned into 
the xhoI and sfiI restriction sites of pCMV-Myc vector (Clontech). The riboprobe 
used in I was produced from a 598-bp Tdrd5 cDNA fragment cloned into pCRII-
TOPO Dual Promoter Vector (Invitrogen). In III the technique was used when 
human RHPN1 was expressed in mammalian cells using the pcDNA4/TO/myc-His-
A expression vector (Invitrogen). The construct was prepared by PCR amplification 
of the full-length cDNA encoding human RHPN1 from a corresponding IMAGE 
cDNA clone IRATp970F0343D and subsequently cloned into the EcoR1-XbaI sites 
of pcDNA4/TO/myc-His-A.  In order to evaluate the cis-regulatory potentials of 
three human conserved sequences with single nucleotide polymorphisms in IV 
both in vitro and in vivo DNA sequences were amplified using human material and 
cloned into pCRII-TOPO vectors (Invitrogen) and then subsequently sub cloned 
into either the luciferase pGL4.26 plasmid (Promega) between SacI and XhoI sites 
or a Tol2-based plasmid containing a GFP cassette under the Nphs2 promoter. 
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3.19 POLYMERASE CHAIN REACTION (PCR) [I, III] 
A biochemical method in which cDNA is amplified through a series of annealing/ 
elongation cycles.   The method was used in I to determine Tdrd5 expression in a 
panel of mouse tissues using a commercial cDNA library (Clontech Mouse Multiple 
tissue cDNA MTC panel 1) and in III to amplify full-length human RHPN1 from a 
corresponding IMAGE cDNA clone IRATp970F0343D. 
3.20 PRIMARY CELL CULTURE [III] 
We used primary podocyte cell cultures from seeded mouse glomerular explants of 
both wild type and Rhpn1 knock out animals [III] in order to asses RHPN1 
subcellular expression pattern and  as an attempt to delineate its molecular 
function. 
3.21 PROTEIN INTERACTION NETWORK ANALYSIS [II] 
The protein–protein interaction information was downloaded from the Human 
Protein Reference Database (http://www.hprd.org/, release 9). The database 
curated the human protein-protein interaction information from published 
literatures. The mouse genes were mapped to the corresponding homologous 
human genes by using the NCBI HomoloGene assembly 
(http://www.ncbi.nlm.nih.gov/homologene). The R program (http://www.r-
project.org/) was used for the data processing, and Rgraphviz package was used 
to visualize the interaction networks (233). 
3.22 QUANTITATIVE REAL TIME –PCR (QRT-PCR) [I, III, IV] 
 A method based on the same principle as the polymerase chain reaction but with 
the main difference that the amplified DNA is detected as the reaction progresses 
(in real time (RT-))  making it a quantitative (q-) method. The method was used in I 
to quantitatively determine tdrd5 expression in fractioned zebrafish tissue from wt 
as well as from tdrd5 mutant larvae. In III and IV the method was used to 
quantitatively determine Rhpn1, Rhpn2, Synpo [III] and Nck1 [IV] expression in 
mouse glomeruli as well as in differentiated/undifferentiated immortalized human 
podocytes [III].   
3.23 REVERESE TRANSCRIPTION [I, III, IV] 
Reverse transcription is a method where the enzyme reverse transcriptase is used 
to generate a complementary DNA (cDNA) sequence from a RNA template. It was 
used to generate cDNA from RNA isolated from mouse glomeruli [I, III, IV] and 
from zebrafish glomeruli and fractionated zebrafish larvae homogenate [I]. In IV the 
method was used generate cDNA from transformed primary human lymphocytes. 
3.24 REVERSE TRANSCRIPTION-PCR (RT-PCR) [I, III] 
A biochemical method where cDNA reversibly transcribed from isolated RNA using 
the reverse transcriptase enzyme is amplified through a series of annealing/ 
elongation cycles.  In I the method was used to qualitatively determine Tdrd5 
transcript localization to fractioned mouse kidney tissues samples (glomeruli and 
kidney fraction lacking glomeruli), as well as for amplification of both Tdrd5 
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transcripts for subsequent cloning purposes. In I and III it was used to qualitatively 
determine transcript expression in FAC sorted total mouse glomerular cell- 
population. 
3.25 RNA SEQUENCING [II] 
In II the RNA library construction and RNAseq were performed at BGI-Hong Kong Co., 
HKG using the Illumina HiSeq 2000 platform and True Seq library construction (Illumina). 
3.26 SDS-PAGE [II, III] 
A biochemical method that utilizes the anionic detergent Sodium dodecyl sulfate in 
SDS- polyacrylamide gels to impart a negative charge to proteins in this way 
linearizing and adding a negative charge to them which makes it possible to 
separate them during electrophoreses. The gel may then be used further for 
Western Blotting [I, III, IV] or as in paper II and III where the gel was stained with 
Coomassie Brilliant Blue to analyze the existence of albumin in urinary samples 
from mice.  
3.27 STATISTICS [I, II, III, IV] 
Data of luciferase assay [IV] and qPCR in I, III, IV was statistically analyzed by t-
test. In II statistics test were performed using the global test algorithms in the 
Cufflinks package (234) in order to identify the genes differentially expressed 
between the different stages of ADR treated glomerular samples and the control. 
In IV the Fisher’s exact test was used for analysis of zebrafish GFP expression 
rate. The Fisher’s exact test and t-test were used for association analysis of clinical 
data with genotypes [IV]. 
3.28 TRANSGENIC ANIMALS [I, III, IV] 
The definition of a transgenic animal is when genetic material has been transferred 
naturally, or by genetic engineering from one organism to another. In III a Rhpn1 
null mouse was created according to the gene targeting technique described 
previously. The excised exons 1-4 of Rhpn1 were here substituted for a green 
fluorescent protein cassette.  In III a mouse expressing enhanced yellow 
fluorescent protein (EYFP) in the podocytes was produced by crossing a mouse 
expressing the EYFP gene under the Gt(ROSA)26Sor locus with an interposed 
floxed STOP sequence with a transgenic mouse expressing the Cre recombinase 
under the control of the Nphs2 promoter. FAC sorted glomerular cells from this 
mouse strain was also used in I. Rhophilin-1/Rhophilin-2 double knock out mice 
were generated by intercrossing Rhpn1+/− and  Rhpn2+/− mice of a mixed C57BL/6, 
129Sv, and CD1 genetic background III. RhoA podocyte-specific deletion in mouse 
of a Rhophilin-1 null background was achieved by crossing triple transgenic 
heterozygous mice (Rhpn1+/−; Nphs2cre/+; RhoAfl/+) of a mixed C57BL/6 and 129Sv 
genetic background [III].  A transgenic zebrafish line (235) was used in I that 
express GFP under the podocyte specific podocin promoter allowing for the 
visualization of the pronephric glomerulus.    
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3.29 TRANSIENT TRANSFECTION [I, III, IV] 
Transfection is the process of introducing nucleic acids into cultured metazoan 
cells by opening transient pores in the cell membrane allowing uptake of material.   
The transient transfections were performed using Lipofectamine 2000 (Invitrogen) 
which is a cationic lipid that encloses the nucleic acid forming liposomes that fuses 
with the cell membrane and deposit their cargo inside the cell. The method was 
used in paper I to introduce expression vectors containing the two myc-tagged 
Tdrd5 splice variants into human embryonic kidney (HEK) cells in order to produce 
myc-tagged proteins by using the cells protein expression system. In III we 
transiently transfected and expressed RHPN1 and a constitutively active RHOA 
construct to investigate their separate and concerted role on a cellular level. In 
paper IV HEK cells were transfected with expression vectors containing various 
single nucleotide polymorphism sequences cloned in frame with a luciferase 
cassette were after the expressed products were used in the luciferase assay.  
3.30 TUNEL STAINING [II] 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) is a 
biochemical method that detects DNA fragmentation that is result from apoptosis. 
The enzyme terminal deoxynucleotidyl transferase (TdT) catalyzes the addition of 
the secondarily labeled dUTP to the nicked DNA, thus visualizing the break. 
TUNEL staining was used in paper II to visualize apoptosis in glomeruli of 
Adriamycin injected mice. 
3.31 WESTERN BLOT [I, III, IV] 
 An analytical technique used to detect specific proteins in a sample of tissue 
homogenate or extract which is separated by electrophoreses on a gel whereby 
the proteins are blotted on to a membrane, with the subsequent incubation with 
protein- specific labelled antibodies. Detection is achieved by incubation with a 
HRP conjugated secondary antibody raised against IgG from the host of the 
primary antibody. The HRP, in the presence of a chromogenic substrate, produces 
a detectable signal. 
3.32  ZEBRAFISH MORPHOLINO KNOCK DOWN TECHNIQUE [I] 
The method is used as a reverse genetic tool where genes are repressed using 
antisense morpholinos whereby the phenotype is analyzed. Morpholinos are 
modified ~25-base long antisense nucleotides that are injected into the yolk of 
fertilized zebrafish egg at the 1-2 cell stage. The morpholino then diffuses from the 
yolk into the dividing cell/cells. The antisense oligo could be designed to hybridizes 
to a pre-mRNA at a splice site hindering the correct splicing of the transcript (splice 
blocker) or it could be designed to hybridize to the ATG site blocking its translation 
on the ribosomes (translational blocker).  At 4 dpf the phenotype of the larvae is 
analyzed. The technique was used in paper I where tdrd5 was repressed using 
both a translational blocker and a splice blocker. 
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4 RESULTS AND DICUSSION 
The kidneys have several function one of them being to filter waste products from 
the blood and excrete them through the urine. The ultimate structure responsible 
for this sieving is the glomerular filtration barrier containing mesangial and 
endothelial cells as well as podocytes, together with the glomerular basement 
membrane and the slit diaphragm. Proper structure, function and concerted cellular 
interplay are a prerequisite for renal health. Glomerular damage underlies as much 
as two-thirds of all chronic kidney disease cases leading to ESRD that constitutes 
an enormous socioeconomic burden. The molecular pathomechanism are likely to 
be many and the causes of most glomerular diseases are poorly understood. The 
present work is a part of a large project aimed at generating new knowledge about 
glomerular development, function and disease. Papers I and II are the direct result 
from the large-scale initiative (236-238) where RNA from normal and healthy 
glomeruli were used to assemble a glomerulus specific GlomChip from which both 
Tdrd5 and Rhpn1 were identified. For paper III the large amount of glomeruli and 
subsequent RNA isolation was imperative for the state of the art RNA deep 
sequencing undertaken. Isolation of glomeruli from two mouse strain carrying the 
nephropathy-prone 129/Sv allele and nephropathy-resistant C57BL/6 allele 
respectively identified NCK1 as a protein differentially expressed in these mouse 
strains. 
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4.1 PAPER I 
Our previous efforts to profile the global transcriptome of the kidney glomerulus 
through microarrays (238) revealed Tdrd5 as a highly enriched transcript. Tdrd5  
draw our attention as it was positioned head to head with the Nphs2 gene  which is 
a podocyte-specific protein associated with hereditary proteinuric disease (175), a 
genomic arrangement that was shown to be conserved. Consequently, it was 
decided to further investigate and characterize TDRD5’s role. 
In order to investigate TDRD5 localization at the transcriptional level I used 
RT-PCR on mouse cDNA tissue panel library, FAC sorted mouse podocytes and 
mouse glomeruli as well as in situ hybridisation on mouse snap frozen kidney 
sections, whereby I show that Tdrd5 is an, apart from mouse testis (239, 240), a 
podocyte specific transcript with two splice variants. Furthermore it was shown by 
qPCR on cDNA reversibly transcribed from RNA isolated from GFP-expressing 
glomeruli of 3dpf transgenic zebrafish larvae (235), tdrd5 to be glomeruli enriched 
transcript. TDRD5 protein localized to mouse glomeruli as determined by Western 
Blot using Myc-tagged transcripts of the two splice variants as positive controls. 
Immuno Gold Electron Microscopy on human kidney sections further specified the 
protein expression to be enriched in the foot-processes of the podocytes. 
Morpholino injection using both translational and transcriptional blockers into 
fertilized zebrafish egg at 1-2 cell stage was used to study tdrd5 ablation in an in 
vivo setting. The histological effects of tdrd5 knock down were studied using 
hematoxylin/eosin staining on 6 µm zebrafish sections which revealed a disturbed 
glomerular morphology and distended tubules. Tdrd5 knock down effect on the 
filtration barrier ultra-structure depicted by transmission electron microscopy 
revealed grossly unaffected podocytes but with a disturbed capillary endothelium 
and distended capillaries, which were also reduced in number.  
 The results of this paper positioned the TDRD5 head-to-head with the 
disease-linked NPHS2 gene (175) in vertebrate genomes and revealed highly 
conserved sequences through different species. Very little is known about TDRD5, 
but it has previously been shown to be highly expressed in the mouse testis (239, 
240). Our studies demonstrated that TDRD5 is also highly expressed in renal 
podocytes, importantly; the protein is likely to have a role in glomerular 
development and function as silencing of tdrd5 expression in zebrafish resulted in 
pronephros abnormalities. As yet, we or others have not yet shown the gene to be 
associated with any human kidney disease. 
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4.2 PAPER II 
One way to increase the understanding of mechanisms for glomerular disease is to 
elucidate glomerular expression signatures using either microarrays or RNAseq. This 
needs to be done for many glomerulopathies and glomerular disease models to obtain a 
good picture of the pathogenic processes in the kidney.  
 In this study, we made use of an Adriamycin-induced FSGS-like (focal segmental 
glomerular sclerosis-like) proteinuric mouse model. In this model, severe proteinuria 
develops, reaching maximum at 7 days after injection of Adriamycin. Then there is partial 
recovery, but the glomerular function and pathology do not normalize.  The mice were 
weighed on a daily basis and spot-urine, blood samples, kidneys as well as RNA extracted 
from glomeruli were sampled during the 14 day duration of the experiment.  
Weight curves, urinary albumin and urinary albumin to creatinine levels as well as 
blood urea nitrogen levels all witness of an acute phase of renal injury day4 reaching its 
maximum at day7 where after urinary and blood levels are somewhat alleviated. 
Ultrastructurally segmental foot processes effacement was evident at day seven and at 14 
days histology revealed resorption droplets and intraluminal casts in the tubular 
compartment with some glomeruli showing segmental sclerosis. 
 The acute phase of injury may be related to the effect of Adriamycin which is known 
to induce DNA damage through reactive oxygen species (ROS) (241) something that 
seem to be reflected in the p53 pathway being the most significantly upregulated pathway 
day4  according to the RNA-seq data, with Psrc1 and Eda2 being the top up-regulated 
genes. They are both transcriptional target of p53 (242, 243). Even though p53 is not itself 
differentially regulated in our screen,  Mdm2 which is a protein that functions to keep p53 
at low levels in unstressed cells by continuous ubiquitination targeting p53 for degradation 
(244), is in our screen significantly regulated day4. The protein-protein interaction network 
described previously (245) linked Mdm2 to the expression of Trp53inp1, Hipk2,  Pja1,  
Rpl11 and  Ccng which are all significantly regulated, as well as Sesn2 and Gpx1 two 
antioxidant genes that p53 trans activates to keep ROS at non-toxic levels at physiological 
conditions (246). The TUNEL staining also reflect the apoptosis of glomerular cells as the 
number of apoptotic positive cells gradually increased after ADR injection, reaching 
maximum at 14 days after ADR injection. 
 The Adriamycin mouse model is characterized by podocyte foot process effacement 
which means there is a high turnover of cytoskeletal components or molecules related to 
cytoskeleton maintenance. As such activities are known to induce ER stress (247), the 
differential regulation of Hspa5, Caspase12 and Ddit3, three molecules that are 
components of the ER stress pathway in podocytes (248),  could be expected. 
Collectively, these observations suggest that podocyte apoptosis during progression of 
glomerulopathy might be associated with ER stress. 
 In this study, as we have done in two previous unpublished global glomeruli transcript 
screens, one of them being data derived from RNA-sequencing of Rhpn1 null mice found 
the hemoglobin genes, Hba-a1 and Hbb-bs to be the two most significantly down regulated 
transcripts day4. We find it likely that the expression of Hbb-bs and Hba-a1 in our screen 
stems from the mesangial cell population of the glomeruli as a previous report has 
localized the hemoglobins to the rat glomerular mesangial cells both on transcriptional as 
well as on protein level (249). In the same study the authors show that the hemoglobins 
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are transiently up regulated under the prevailing experimental hypoxic conditions (249). 
The investigators also overexpressed the α and β-globins in the SV40-MES13 murine 
mesangial cell line and found that reactive oxygen species production was reduced thus 
ameliorating oxidative stress when induced by hydrogen peroxide. Based on their results 
they speculate that the proteins potential function in the mesangial cells includes 
antioxidant defense. Thus, we speculate that the regulation of these transcripts may be 
related to a cellular response acting on oxidative stress. The globin family today consists 
of the hemo- and myoglobin (250),  plus the  more recently discovered ubiquitously 
expressed cytoglobin (251) and neuroglobin which is predominately expressed in the 
nerve cells (252). They are all found to bind oxygen in a reversible way but the cytoglobin 
and neuroglobin are furthermore believed to act as O2 consuming enzymes or as O2 
sensors or might being involved in NO/O2 chemistry (253).  Interestingly neuroglobin was 
also found to be significantly down regulated day 4 and 7 in our screen. Neuroglobin is 
mainly found in the nervous system and considering the close relationship between the 
transcriptome of the neurons and the podocytes (23) we find it likely that the neuroglobin 
expression is of podocyte origin.  
The circadian rhythm pathway was the highest regulated pathway between control 
and day 7, with 27% of the member proteins being differentially regulated. That the renal 
function is oscillating according to circadian rhythmicity pattern was first documented in the 
middle of 19th century (254). The proteins constituting the core of the feedback loop that 
generates the transcriptional rhythms of approximately 24 h periodicity   BMAL1, CLOCK 
and NPAS2 which dimerize into various heterodimers whereby they activate the 
transcription and translation of their repressors PER and CRY (255) during the daytime,  
are down regulated in our screen,  all of them except CLOCK significantly. Moreover the 
melatonin receptor Mt2 which is a G-protein coupled, 7-transmembrane receptor 
responsible for melatonin effects on mammalian circadian rhythm was significantly down 
regulated day4 and 7. Considering the large fraction of the regulated proteins involved in 
the circadian rhythm and the melatonin receptor it was not very surprising to find all three 
proteins taking part of the G protein cascade of visual transduction (256) Rhodopsin (Rho), 
Transducin (Gnat1) and cGMP phosphodiesterase ((Pde4b and 4d) (257)) to be 
significantly down regulated day4 and 7 (Rho, Gnat1 and Pde4d also day 14).  
In order to identify the genes differentially expressed between the different stages of 
ADR treated glomerular samples and the controls, statistics test were performed using the 
global test algorithms in the Cufflinks package (234), The result showed that 721 genes 
out of the 38,742 total genes detected were significantly differentially expressed between 
ADR-treated glomeruli at the 4-day stage and the controls (False Discovery Rate < 0.05), 
and 363 genes were differentially expressed genes at 7 days stage and 637 differentially 
expressed genes at 14 days stage.  
We conclude that The ADR-proteinuric mouse model is a stable model of chronic 
progressive nephropathy, and that the transcriptome profile generated from RNAseq 
technology is valuable for dissecting the molecular mechanisms of the proteinuria.  
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4.3 PAPER III 
RHPN1 was disclosed as one of the highest expressed glomerulus-enriched 
transcripts on the microarray previously performed by our group (238). 
Furthermore, the transcript was in the same study localized to the podocytes using 
in situ hybridization (238).  Rhophilin-1 was identified almost 20 years ago as a 
Rho GTPase interacting protein (258) and in another study shown to be expressed 
in the fibrous sheet of the mouse sperm tail (259). To our knowledge, no data have 
since been presented when it comes to expression or biological function of this 
protein. 
The aim of this paper was to further delineate RHPN1 spatiotemporal 
expression in glomeruli, as well as investigate by which mechanisms it exerts its 
functions using in vivo and in vitro methods.  
 We used frozen mouse kidney sections and FAC sorted mouse podocytes to 
show that Rhpn1 is exclusively expressed in the podocytes of the late capillary 
stage of glomerulogenesis. We produced a Rhpn1 -/- mouse where new-born pups 
were phenotypically normal at birth but developed albuminuria at two weeks of 
age. The glomeruli of these mice presented focal glomerular sclerotic lesions with 
an expanded mesangium similar to what may be seen in FSGS or diabetic 
nephropathy. Ultrastructurally, a widened glomerular basement membrane and 
effaced foot processes were noted indicative of dysregulation of the actin 
cytoskeleton. To further investigate the mechanism giving rise to the above 
phenotype we made use of primary podocyte cell cultures emanating from 
glomeruli of Rhpn1 knock out and wild type mice, as well as immortalized human 
podocyte cell cultures. The primary podocytes showed RHPN1 to be expressed at 
the leading edge of the cell. Whereas the wild type podocytes showed a polarized 
and highly arborized subcortical actin cytoskeleton structure, the Rhpn1 -/- 
podocytes appeared more stellate and less curved at the plasma membrane with 
prominent ventral stress fibres spanning the cell body suggesting that RHPN1 
interacts with cytoskeleton proteins. RHPN1 transient transfection of immortalized 
human podocyte cells led to a substantial downregulation of the otherwise 
prominent actin stress fibres of this cell culture system. Transfection of a 
constitutively active RHOA expressing construct led to an expected increase of 
stress fibre formation, which we by co-transfection with RHPN1 were able to 
alleviate. RHOA is acknowledged to be a major determinant for the formation of 
actomyosin stress fibre formation (260), and the stress fibre associated non muscle 
II regulatory light chain is known to be a target of ROCK which is and RHOA 
downstream effector (261). To this end we investigated the phosphorylation status 
of the stress fibre associated NM II RLC both in vivo in kidney sections of Rhpn1-/- 
mice and in RHPN1 transfected / vector transfected immortalized human 
podocytes.  These in vivo and in vitro studies both showed a marked increase of 
phosphorylated NM II RLC expression in the absence of RHPN1, indicating that 
RHPN1 is a regulator of RHOA activity. The actin cytoskeleton is appreciated to be 
a major constituent of podocyte physiology and function and RHOA together with 
RAC1 and CDC42 are well recognized as being the determinants of its proper 
regulation (209, 210, 262-264). 
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 In summary, this study has identified Rhophilin-1 as a novel podocyte specific 
protein, regulating RHOA activity and the consequent phosphorylation of the non-
muscle myosin regulatory light chain through RHOA downstream effectors, thus 
being an integral component of the glomerular filtration barrier. Its role in 
glomerular diseases remains to be studied.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
4.4 PAPER IV 
This paper is a part of studies in the laboratory on the potential regulatory role of a 
previously reported genetic association of the single nucleotide polymorphism 
(SNP), rs1866813 at 3q locus with diabetic nephropathy (265). The glomerulus is a 
primary target of this devastating diabetes complication, but the molecular 
pathomechanism of this disease is still poorly understood.  The SNP is located 
approximately 70 kb downstream of a cluster of the four genes: STAG1, TMEM22, 
NCK1 and IL-20RB, of which mouse NCK1 has been associated with foot process  
formation during podocyte development in mice and regeneration following 
glomerular injury (266).  
 In this study we tested in a series of experiments whether the different allelic 
genotypes of the SNP differentially regulate downstream targets. In vitro, two 
alleles of the SNP show differential effects on luciferase activity in transfected cells. 
In vivo using transgenic zebrafish larvae we further demonstrate that two alleles of 
the SNP differentially regulate GFP expression in zebrafish podocytes. By 
immunofluorescence staining and Western blotting we showed that only NCK1 of 
the four genes was mainly expressed in mouse glomeruli where it was observed in 
podocytes. We also showed that genotypes of the SNP rs1866813 correlated with 
NCK1 expression in immortalized lymphocytes from diabetic patients, where the 
risk allele was associated with increased NCK1 expression compared to the non-
risk allele. We also showed that in glomeruli NCK1 is differential expressed in two 
mouse strains carrying the nephropathy-prone 129/Sv allele and nephropathy-
resistant C57BL/6 allele respectively.  
We conclude from this work that the DN-associated SNP rs1866813 is a 
remote cis-acting variant differentially regulating glomerular NCK1 expression, and 
that glomerular NCK1 may play a role in the pathogenesis of diabetic nephropathy. 
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5 GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Since the first description of the slit diaphragm as imaged by Rodewald and 
Karnovsky in 1974 (140) using electron microscopy on mouse and rat kidney 
tissue, and the discovery of nephrin (153) and its subsequent localization to the slit 
diaphragm much has happened in the glomerular research area. Previously and 
historically the main filtering function of the GFB was attributed to the GBM but in 
the recent decades the research community has emphasize the podocytes as the 
major culprit of glomerular disease. Even though foot process effacement with the 
concomitant disappearance of the SD is noted in most cases when proteinuria is 
present, it is today recognized that the concerted interplay with all the GFB 
constituents is important for proper filtering function. 
 Considering the podocyte cell morphology and its transcriptome that closely 
resembles that of the neurons it is tempting to hypothesize around TDRD5 function 
in the podocytes. That the neurons are in need of the neuronal granules that tether 
mRNA at distant synapses for rapid translation is known and it is easy to draw 
parallels to the podocytes and the slit diaphragm. There is yet no published data of 
the existence of such granules but there is evidence that supports their existence. 
Considering TDRD5 function in the mouse germinal granules where it takes part in 
the scaffolding and processing of pi-RNA TDRD5 could be hypothesized to take 
part of such granules. 
 The development of RNA sequencing allows for high resolution identification 
of de novo transcripts in biological samples. The method is highly quantitative and 
currently even allows the generation of full transcriptomes from single cells (267). 
This opens up for extensive characterization of global expression signatures even 
from single glomeruli and the method is likely to yield a large body of exciting 
expression profiles during development and in disease in the near future. Such 
profiles can hopefully provide a new source for drug target discovery. The 
glomerular screen presented here on glomeruli in Adriamycin-induced nephrosis is 
an example which opens up for investigation of proteins and pathways that are 
regulated when podocytes are targeted. For example, the unexpected result that 
the hemoglobin alpha and beta chains being the most down regulated transcripts 
day4 as compared to control needs to be further investigated. ‘ 
 The significance of RHPN1 regulation of RHOA and its effect on podocyte 
actin cytoskeleton is easy to appreciate as most mutations or injury mechanisms 
finally result in rearrangement of actin fibers, podocyte foot process effacement, 
and proteinuria. Thus further investigations need to be done when it comes to the 
fine-tuning of this relationship. 
The finding presented in paper IV where the expression of NCK1 is shown to 
be regulated by the diabetic nephropathy associated allelic genotypes of SNP 
r1866813 highlights the level of complexity at which the genome is regulated. With 
the advent of new generation sequencing techniques the speed with which such 
intergenic regulatory elements are discovered will most certainly increase. 
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